Should You Consider Investing in Abha Power and Steel IPO?
Akums Drugs and Pharmaceuticals IPO Subscription Status
Last Updated: 2nd August 2024 - 10:32 am
Akums Drugs and Pharmaceuticals IPO Subscription - Day-3 Subscription at 63.44 times
Akums Drugs and Pharmaceuticals IPO closed on 1 Aug. Shares of Akums Drugs and Pharmaceuticals are likely to be listed on 6 August on BSE, NSE. As of 1 Aug 2024, Akums Drugs and Pharmaceuticals IPO received bids for 96,18,57,204 shares much more than the 1,51,62,239 shares offered. It means Akums Drugs and Pharmaceuticals IPO was oversubscribed 63.44 times by the end of day 3.
Here are the subscription details for Akums Drugs and Pharmaceuticals IPO as of Day 3 (1 August 2024 at 6:16 pm):
Employees (N.A.) | QIBs (90.09 X) | HNI / NII (42.10X) | Retail (20.80X) |
Total (63.44X) |
Akums Drugs and Pharmaceuticals IPO subscription was mainly driven by QIB investors on day 3, followed by High NetWorth Individuals and Non Institutional Investors (NIIs), while retail investors showed less interest on day 3. QIBs and HNIs/NIIs generally increase their subscriptions in the final hours of the last day. Overall subscription figures do not include the anchor portion or the market making segment of the IPO.
QIBs are large institutional investors like mutual funds and insurance companies, while HNIs/NIIs are wealthy individual investors and smaller institutions.
Subscription Status of Akums Drugs and Pharmaceuticals IPO for Days 1, 2, and 3
Date | QIB | NII | Retail | Total |
Day 1 Jul 30, 2024 |
0.43 | 1.97 | 3.46 | 1.39 |
Day 2 Jul 31, 2024 |
0.96 | 8.50 | 9.09 | 4.46 |
Day 3 Aug 01, 2024 |
90.09 | 42.10 | 20.80 | 63.44 |
On day 1, Akums Drugs and Pharmaceuticals IPO was subscribed 1.39 times. By day 2, the subscription status had risen to 4.46 times and on day 3, it reached 63.44 times.
Here are the subscription details for Akums Drugs and Pharmaceuticals IPO by category as of Day 3:
Investor Category | Subscription (times) | Shares Offered | Shares Bid For | Total Amount (₹ in Crore) |
Anchor Investors | 1.00 | 1,22,05,912 | 1,22,05,912 | 828.781 |
QIB Investors | 90.09 | 81,37,276 | 73,31,17,770 | 49,778.70 |
HNIs / NIIs | 42.10 | 40,68,637 | 17,13,07,510 | 11,631.78 |
bNII (bids above ₹10L) |
47.43 | 27,12,425 | 12,86,49,664 | 8,735.31 |
sNII (bids below ₹10L) |
31.45 | 13,56,212 | 4,26,57,846 | 2,896.47 |
Retail Investors |
20.80 | 27,12,424 | 5,64,23,114 | 3,831.13 |
Employees | 4.14 | 2,43,902 | 10,08,810 | 68.50 |
Total | 185.82 | 1,51,62,239 | 96,18,57,204 | 65,310.10 |
Data Source: NSE
For Akums Drugs and Pharmaceuticals IPO Qualified Institutional Buyers (QIBs) showed good interest on day 3 and subscribed 90.09 times. HNIs / NIIs portion subscribed 42.10 times while Retail Investors subscribed 20.80 times. Overall, Akums Drugs and Pharmaceuticals IPO was subscribed 63.44 times on Day 3
Akums Drugs and Pharmaceuticals IPO - Day 2 Subscription at 4.45 Times
Akums Drugs and Pharmaceuticals IPO will close on 1 Aug. Shares of Akums Drugs and Pharmaceuticals are likely to be listed on 6 August on BSE, NSE. By 31 July 2024, Akums Drugs and Pharmaceuticals IPO received bids for 6,74,40,450 shares much more than the 1,51,62,239 shares available. It means Akums Drugs and Pharmaceuticals IPO was oversubscribed by 4.45 times by the end of day 2.
Here are the subscription details for Akums Drugs and Pharmaceuticals IPO as of Day 2 (31st July 2024 at 5:59 pm):
Employees (2.25X) | QIBs (0.96X) | HNI / NII (8.49X) | Retail (9.05X) | Total (4.45X) |
Akums Drugs and Pharmaceuticals IPO subscription was mainly driven by retail investors on day 2, followed by High NetWorth Individuals and Non Institutional Investors (NIIs), at last Qualified Institutional Buyers (QIBs) showed less interest on day 2. QIBs and HNIs/NIIs generally increase their subscriptions in the final hours of the last day. Overall subscription figures do not include the anchor portion or the market making segment of the IPO.
QIBs are large institutional investors like mutual funds and insurance companies, while HNIs/NIIs are wealthy individual investors and smaller institutions.
Here are the subscription details for Akums Drugs and Pharmaceuticals IPO by category as of Day 2:
Investor Category | Subscription (times) | Shares Offered | Shares Bid For | Total Amount (₹ in Crore) |
Anchor Investors | 1.00 | 1,22,05,912 | 1,22,05,912 | 828.781 |
QIB Investors | 0.96 | 81,37,276 | 77,75,702 | 527.970 |
HNIs / NIIs | 8.49 | 40,68,637 | 3,45,58,348 | 2,346.512 |
bNII (bids above ₹10L) | 8.87 | 27,12,425 | 2,40,70,596 | 1,634.393 |
sNII (bids below ₹10L) | 7.73 | 13,56,212 | 1,04,87,752 | 712.118 |
Retail Investors | 9.05 | 27,12,424 | 2,45,58,116 | 1,667.496 |
Employees | 2.25 | 2,43,902 | 5,48,284 | 37.228 |
Total | 4.45 | 1,51,62,239 | 6,74,40,450 | 4,579.207 |
Data Source: NSE
On day 1, Akums Drugs and Pharmaceuticals IPO was subscribed 1.39 times. By day 2, the subscription status had risen to 4.45 times. Qualified Institutional Buyers (QIBs) did not show much interest on day 2 and subscribed 0.96 times. HNIs / NIIs portion subscribed 8.49 times while Retail Investors subscribed 9.05 times. Overall, Akums Drugs and Pharmaceuticals IPO was subscribed 4.45 times on Day 2
Akums Drugs and Pharmaceuticals IPO - Day 1 Subscription at 1.39 Times
Akums Drugs and Pharmaceuticals IPO will close on 1 Aug. Shares of Akums Drugs and Pharmaceuticals are likely to be listed on 6 August on BSE and NSE.
On 30 July 2024, Akums Drugs and Pharmaceuticals IPO received bids for 2,11,10,606 shares, much more than the 1,51,62,239 shares available. It means Akums Drugs and Pharmaceuticals IPO was oversubscribed by 1.39 times by the end of Day 1.
Here are the subscription details for Akums Drugs and Pharmaceuticals IPO as of Day 1:
Employees (1.11X) | QIBs (0.43X) | HNI / NII (1.97X) | Retail (3.46X) | Total (1.39X) |
Akums Drugs and Pharmaceuticals IPO subscription was mainly driven by retail investors on Day 1, followed by High Net Worth Individuals and Non-Institutional Investors (NIIs), with Qualified Institutional Buyers (QIBs) showing less interest on Day 1. QIBs and HNIs/NIIs generally increase their subscriptions in the final hours of the last day. Overall subscription figures do not include the anchor portion or the market-making segment of the IPO.
QIBs are large institutional investors like mutual funds and insurance companies, while HNIs/NIIs are wealthy individual investors and smaller institutions.
Here are the subscription details for Akums Drugs and Pharmaceuticals IPO by category as of Day 1:
Investor Category | Subscription (times) | Shares Offered | Shares Bid For | Total Amount (₹ in Crore) |
Anchor Investors | 1 | 1,22,05,912 | 1,22,05,912 | 828.781 |
QIB Investors | 0.43 | 81,37,276 | 34,76,242 | 236.037 |
HNIs / NIIs | 1.97 | 40,68,637 | 80,11,388 | 544.265 |
bNII (bids above ₹10L) | 2.04 | 27,12,425 | 55,36,872 | 375.954 |
sNII (bids below ₹10L) | 1.83 | 13,56,212 | 24,74,516 | 168.020 |
Retail Investors | 3.46 | 27,12,424 | 93,75,608 | 636.604 |
Employees | 1.11 | 2,43,902 | 2,69,830 | 18.321 |
Total | 1.39 | 1,51,62,239 | 2,11,10,606 | 1,433.410 |
Data Source: NSE
On Day 1, Akums Drugs and Pharmaceuticals IPO was subscribed 1.39 times. Qualified Institutional Buyers (QIBs) did not show much interest on Day 1 and subscribed 0.43 times. HNIs / NIIs portion subscribed 1.97 times while Retail Investors subscribed 3.46 times. Overall, Akums Drugs and Pharmaceuticals IPO was subscribed 1.39 times.
About Akums Drugs and Pharmaceuticals Ltd
Founded in 2004, Akums Drugs and Pharmaceuticals Limited is a top pharmaceutical contract development and manufacturing organization (CDMO). They offer product development, manufacturing, R&D, regulatory dossier preparation, and testing services, producing and selling branded drugs and APIs.
Akums manufactures various dosage forms, serving 26 of the top 30 Indian pharmaceutical companies in 2023. With 10 manufacturing units and a capacity of 49.21 billion units annually, they plan to add two more units by FY 2025. Their facilities are accredited by EU-GMP, WHO-GMP, and US NSF.
Highlights of Akums Drugs and Pharmaceuticals IPO:
IPO Price Band: ₹646 to ₹679 per share.
Minimum Application Lot Size: 22 shares.
Minimum Investment for Retail Investors: ₹14,938.
Minimum Investment for High Net-worth Investors (HNI): 14 lots (308 shares), ₹209,132.
Registrar: Link Intime India Private Ltd.
Akums Drugs and Pharmaceutical will utilize the net proceeds towards repayment or prepayment of the company's and its subsidiaries’ debts, supporting the company's working capital needs and covering general corporate expenses.
Trending on 5paisa
02
5paisa Research Team
Discover more of what matters to you.
IPOs Related Articles
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.